Crossmark

Synthesis and preliminary preclinical evaluation of fluorine-18 labelled isatin-4-(4-methoxyphenyl)-3-thiosemicarbazone ([18F]4FIMPTC) as a novel PET tracer of P-glycoprotein expression

Crossref DOI link: https://doi.org/10.1186/s41181-018-0046-z

Published Online: 2018-09-21

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Verbeek, Joost

Eriksson, Jonas

Syvänen, Stina

Huisman, Marc

Schuit, Robert C.

Molthoff, Carla F. M.

Voskuyl, Rob A.

de Lange, Elizabeth C.

Lammertsma, Adriaan A.

Windhorst, Albert D.
Funding

Funding for this research was provided by:

EU 7th framework (Health-F5-2007-201380)
License Information

Text and Data Mining valid from 2018-09-21
More Information

Article History

Received: 22 February 2018

Accepted: 18 July 2018

First Online: 21 September 2018

Ethics approval and consent to participate

: All animal experiments were performed in compliance with the Dutch law on animal experimentation and approved by the local animal ethics committee (DEC).

: All authors gave their consent for publication, and please contact author for data requests.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below